Bayesian Capital Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bayesian Capital Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,087	Closed	-$38.2K	–	1196
2023 Q4	$38.2K	Buy	+15,087	New	+$35.1K	﹤0.01%	683
2022 Q4	–	Sell	-40,700	Closed	-$118K	–	1091
2022 Q3	$118K	Buy	+40,700	New	+$171K	0.02%	578

Bayesian Capital Management's SLGC Position: Q1 2024 in Review

Bayesian Capital Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 15,087 shares — an estimated $38.2K sold.

Bayesian Capital Management first reported a position in SLGC in Q3 2022 and held it in 2 quarters. The position peaked at $118K in Q3 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Bayesian Capital Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Bayesian Capital Management sold 15,087 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $38.2K.
Bayesian Capital Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2022 and held it in 2 quarters.
Bayesian Capital Management's SomaLogic, Inc. Class A Common Stock position peaked at $118K in Q3 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.